Navigation Links
Protein May Trigger Colon Cancer
Date:5/5/2008

Excessive levels turn harmless polyps cancerous, study shows

MONDAY, May 5 (HealthDay News) -- The overproduction of a protein may be what starts harmless colon polyps on their journey to becoming malignant tumors, Finnish researchers report.

The University of Helsinki research, published online in Cancer Cell, reveals that PROX1, a protein that controls formation of normal organs in embryos, is produced in excess during the early stages of cancer development. PROX1 even encourages tumor cell growth without additional signals from surrounding normal tissues.

The removal of PROX1 from cancer cells appears to reverse their malignant behavior, suggesting that future research may focus on the protein's use in colon cancer therapies.

Men and women face a lifetime risk of nearly 6 percent for the development of invasive colorectal cancer, making it one of the most common malignancies in the Western world. Past epidemiologic studies have cited obesity and several dietary factors -- including fat, red meat and a lack of vegetables and fiber -- as increasing the risk of the disease.

More information

The National Cancer Institute has more about colorectal cancer screening.



-- Kevin McKeever



SOURCE: University of Helsinki, news release, May 5, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Study in 7,000 men and women ties obesity, inflammatory proteins to heart failure risk
2. First atomic-level look at a protein that causes brain disease
3. OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
4. Detour(R) Unveils Snack Size Protein Bar
5. Genome analysis reveals new protein associated with breast cancer progression
6. OHSU Cancer Institute researchers find connection between protein, prognosis in breast cancer
7. Penn researchers discover modus operandi of heart muscle protein
8. Key Protein Limits Damage of Heart Attack
9. FSU researchers mutant proteins could lead to new treatment for heart disease
10. Signaling protein helps limit damage in heart attack, Jefferson scientists show
11. Stanford researchers unmask proteins in telomerase, a substance that enables cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein May Trigger Colon Cancer
(Date:2/12/2016)... New York, NY (PRWEB) , ... February 12, ... ... latest edition of “Revolutionizing Cancer Care.” , The print component of ... in Chicago, Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation ...
(Date:2/12/2016)... Washington, DC (PRWEB) , ... February 12, 2016 ... ... announce “Managing High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming ... strategies to maintain affordability and access in big-dollar therapeutic categories, such as the ...
(Date:2/12/2016)... ... February 12, 2016 , ... US Sport Camps is pleased to announce the ... in Norwalk, serves as the host site and directing the camps is PGA Professional ... had successful camps in recent years around Des Moines and are fortunate to have ...
(Date:2/12/2016)... ... ... Healthcare careers in the medical laboratory, nursing, and in the imaging field ... staffing leader Aureus Medical Group during the month of January. Aureus Medical specializes in ... and in travel and direct hire opportunities in other allied health fields. , The ...
(Date:2/12/2016)... Middletown, N.J. (PRWEB) , ... February 12, 2016 ... ... Americans is creating explosive growth in the field of long term care. With ... heightened demand for well-trained healthcare professionals in administrative roles in long term care ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ... the Company will ring the Nasdaq Closing Bell at ... York at 4:00 p.m. ET on Tuesday, ... Adrian Adams , will perform the ... to 4:00 p.m. ET.  A live webcast will be ...
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... YORK , Feb. 11, 2016 ... instruments commonly used in laboratories. These may range from ... condensers. Laboratory glassware is made from borosilicate glass because ... Laboratory plasticware, on the other hand, started gaining popularity ... it was easier to replace glass with plastic in ...
Breaking Medicine Technology: